"You can have the fanciest ideas and molecules, but if you can't get them into the cell, they are of no use.”
- Matthew Porteus, co-founder, crispr therapeutics
LIGANDAL AIMS TO FREE HUMANITY FROM COMPLEX DISEASES
THE PROBLEMToday's drugs are not addressing the root causes of diseases, lack key components necessary to develop a precision platform, and are fragmented and costly.
|
THE SOLUTIONDeveloping a complete platform to unlock the human genome to tackle multiple complex diseases and deliver globally accessible personalized medicine.
|
GETTING THERELigandal will take a calculated, programmatic and market-driven approach with four key stages in development to deliver the solution.
|
